Methodology

ChemLifeIntel is an automated intelligence platform covering the global chemical and life sciences value chain. We track regulatory enforcement, trade flows, market movements and clinical milestones across 12,400+ entities — companies, molecules, facilities and regulators.

Every brief is built from official, public-record sources. Primary sources include:

• USFDA
• EMA
• CDSCO
• MHRA
• PMDA
• WHO Prequalification
• ClinicalTrials.gov
• FDA Orange Book

Each intelligence event follows the same pipeline: signal → fact extraction → expert analysis → review → publish. We detect a public signal, extract only non-copyrightable facts, attach those facts to the relevant entities in our knowledge graph, and produce original analyst commentary on what it means for the reader's business.

We use Google Gemini for fact extraction and structured analysis, not for rewriting third-party articles. Source text is never republished; our analysis is original and reviewed against the historical record in our knowledge graph before publication.

Every brief carries a named analyst byline. Our specialist team:

We correct errors promptly. To report an inaccuracy, email compliance@chemlifeintel.com with the brief URL and the specific claim in question.

Industry professionals can submit intelligence for review at /submit. Submissions are fact-checked before any publication decision.